NovaBay Pharmaceuticals, Inc. NBY
Set alert
1.47 USD 0.00 0.00%
As of May 22, 12:37 PM ET
1.47 Day range 1.47
0.36 52-week range 9.10
- YTD
- -94.79%
- 1 year
- -47.32%
- Open
- 1.47
- Prev close
- 1.47
- Mkt cap
- 2.52M
- Vol
- 86.83K
- Avg vol
- 476.87K
- EPS
- -74.61
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.47
- High
- 1.47
- Forward P/E
- -0.63
- Beta
- 0.00
- Short ratio
- 0.07
- Inst. own
- 2.58%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.6314
- 200-d avg
- 1.85
- 1y target
- 3.73
Analyst view
Consensus: none
Price target (mean) 3.73 +153.4% upside
Now 1.47
- Target (low)
- 0.85
- Target (mean)
- 3.73
- Target (high)
- 6.60
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.24 | -0.24 – -0.24 | -46.55 | +99.5% | 2.50M | -32.9% | 1 |
| Next quarter | -0.305 | -0.37 – -0.24 | -5.34 | +94.3% | 3.00M | +14.0% | 2 |
| Current year | -3.26 | -3.26 – -3.26 | -138.60 | +97.7% | 9.90M | -32.8% | 1 |
| Next year | -0.82 | -0.86 – -0.78 | -3.26 | +74.9% | 12.60M | +27.3% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Aug 11, 2023 | Ladenburg Thalmann | Maintained | Buy | Buy |